Joyce Yeung, NP
Adult Health · Brooklyn, NYNPI 1417203456
Payments from drug & device makers
Across 601 payments — averaging $25.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$3K
- AstraZeneca$2K
- Amgen$2K
- Gilead$2K
- Esperion Therapeutics, Inc.$1K
- GSK$1K
- plus $5K from 23 others
What the payments were for
- Speaking & faculty fees$150%
- Food & beverage$15,420100%
- Education$500%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 90 | $2,755 |
| AstraZeneca | 109 | $2,296 |
| Amgen | 56 | $1,960 |
| Gilead | 73 | $1,716 |
| Esperion Therapeutics, Inc. | 29 | $1,174 |
| GSK | 39 | $1,015 |
| Amarin Pharma, Inc. | 30 | $741 |
| Lilly USA, LLC | 32 | $685 |
| Novo Nordisk | 30 | $571 |
| Bayer | 23 | $567 |
| Galderma Laboratories, L.p. | 23 | $471 |
| IBSA Pharma Inc. | 12 | $404 |
| Sanofi-aventis U.S. LLC | 13 | $204 |
| Exact Sciences | 9 | $190 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $99 |
| Ardelyx, Inc. | 1 | $93 |
| Almatica Pharma LLC | 4 | $82 |
| Kowa Pharmaceuticals America, Inc. | 4 | $77 |
| Radius Health, Inc. | 3 | $68 |
| AbbVie | 3 | $55 |
| Merck | 3 | $53 |
| Pfizer | 3 | $45 |
| Nestle Healthcare Nutrition Inc. | 2 | $35 |
| Averitas Pharma Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Philips North America LLC | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Medicure Pharma Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,485 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VascepaIcosapent Ethyl | 1,032 | $453,457 |
| Diclofenac Sodium | 414 | $364,259 |
| FarxigaDapagliflozin Propanediol | 441 | $358,225 |
| Diclofenac Epolamine | 477 | $323,440 |
| RybelsusSemaglutide | 171 | $248,608 |
| SynjardyEmpagliflozin/Metformin Hcl | 240 | $213,121 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 236 | $166,564 |
| ProliaDenosumab | 93 | $160,333 |
| VemlidyTenofovir Alafenamide | 109 | $158,379 |
| Evenity (2 Syringes)Romosozumab-Aqqg | 65 | $155,368 |
| MounjaroTirzepatide | 99 | $133,478 |
| KerendiaFinerenone | 124 | $122,709 |
| JardianceEmpagliflozin | 143 | $114,470 |
| LivaloPitavastatin Calcium | 176 | $102,413 |
| JanumetSitagliptin Phos/Metformin Hcl | 123 | $90,525 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Airsupra | $2,296 | $535,100692 claims |
| Boehringer IngelheimSynjardy, Jardiance, Tradjenta, Jentadueto | $2,755 | $376,297443 claims |
| AmgenProlia, Evenity (2 Syringes) | $1,960 | $315,700158 claims |
| Novo NordiskRybelsus, Ozempic | $571 | $296,238223 claims |
| MerckJanumet, Januvia | $53 | $168,113233 claims |
| GileadVemlidy | $1,716 | $158,379109 claims |
| Lilly USA, LLCMounjaro, Trulicity | $685 | $153,918122 claims |
| BayerKerendia | $567 | $122,709124 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $77 | $102,413176 claims |
| IBSA Pharma Inc.Licart, Flector | $404 | $94,678136 claims |
| GSKTrelegy Ellipta, Shingrix | $1,015 | $73,256158 claims |
| AbbVieLinzess, Restasis | $55 | $60,12790 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.
Other adult health in Brooklyn
- Huiwen YingBrooklyn$17K
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
- Maria Gigante-BaggettEast Syracuse$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.